NYSE: LINLinde Plc Stock
$284.80+2.60 (0.92%)
Updated Apr 9, 2021
LIN Price
$284.80
Fair Value Price
N/A
Market Cap
$149.48B
52 Week Low
$172.76
52 Week High
$286.98
P/E
59.96x
P/B
3.16x
P/S
5.1x
PEG
1.9x
Dividend Yield
1.35%
Revenue
$27.24B
Earnings
$2.50B
Gross Margin
43.5%
Operating Margin
12.71%
Profit Margin
9.2%
Debt to Equity
0.82
Operating Cash Flow
$7B
Beta
0.95
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
LIN Overview
Zen Score
High
Medium
Low
39
Industry average
Reasons for this score
LIN ($284.80) is trading below its intrinsic value of $544.35, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
LIN is poor value based on its earnings relative to its share price (59.96x), compared to the US market average (17.94x)
Valuation
LIN is poor value based on its earnings relative to its share price (59.96x), compared to the US Specialty Chemicals industry average (24.05x)
Valuation
LIN News
Valuation
LIN fair value
Fair Value of LIN stock based on Discounted Cash Flow (DCF)
Price
$284.80
Fair Value
$254.10
Overvalued by
12.08%
LIN ($284.80) is trading below its intrinsic value of $544.35, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
LIN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
59.96x
Industry
24.05x
Market
17.94x
LIN is poor value based on its earnings relative to its share price (59.96x), compared to the US market average (17.94x)
Valuation
LIN is poor value based on its earnings relative to its share price (59.96x), compared to the US Specialty Chemicals industry average (24.05x)
Valuation
LIN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.16x
Industry
4.43x
Market
-0.01x
LIN is good value based on its book value relative to its share price (3.16x), compared to the US market average (-0.01x)
Valuation
LIN is good value based on its book value relative to its share price (3.16x), compared to the US Specialty Chemicals industry average (4.43x)
Valuation
LIN price to earnings growth (PEG)
For valuing profitable companies with growth potential
LIN is poor value relative to its rate of earnings growth, measured by PEG ratio (1.9x)
Valuation
LIN's financial health
Profit margin
Revenue
$7.3B
Net Income
$770.0M
Profit Margin
10.6%
LIN's Earnings (EBIT) of $3.46B can safely cover interest payments on company debt ($16.15B)
Financials
LIN's profit margin has increased (+1.1%) in the last year from (8.1%) to (9.2%)
Financials
Assets to liabilities
Assets
$88.2B
Liabilities
$38.6B
Debt to equity
0.34
LIN's short-term liabilities ($13.74B) exceed its short-term assets ($10.92B)
Financials
LIN's long-term liabilities ($24.91B) exceed its short-term assets ($10.92B)
Financials
LIN's debt to equity ratio (0.82) is considered high
Financials
Cash flow
Operating
$2.4B
Investing
-$1.0B
Financing
-$3.0B
LIN's operating cash flow ($7.43B) is sufficient to service the company's debt ($16.15B)
Financials
Linde Stock FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.